science policy

The U.S. Department of State established a new office intended to develop and coordinate critical and emerging technology foreign policy, including biotechnology, advanced computing, artificial intelligence, and quantum information technologies.  The Office of the Special Envoy for Critical and Emerging Technology began operations Jan. 3. The office will offer policy expertise in technology, diplomatic leadership, and strategic direction for the department.

With the Dec. 20 release of two Requests for Information (RFIs), the White House Office of Science and Technology Policy seeks public input to help guide the development and deployment of the National Biotechnology and Biomanufacturing Initiative, which is intended to use the two disciplines to advance innovative solutions in health, climate change, energy, food security, agriculture, and supply chain resilience.

The National Institute of Standards and Technology (NIST) has released a Request for Information (RFI) to help guide the development of eight emerging technologies.

The Biden administration announced the 30 members of the President’s Council of Advisors on Science and Technology (PCAST) this week. The panel, which is co-chaired by the president’s science advisor and external experts, exists to make science, technology and innovation recommendations to the White House. The administration calls this the most diverse PCAST in its history, which dates back to 1957, including the first women co-chairs. Included among the advisors are two former secretaries under President Barack Obama: Penny Pritzker (Commerce) and Ashton Carter (Defense).

Eric Lander was confirmed by the Senate as director of the White House Office of Science and Technology Policy (OSTP). He will serve as the president’s science adviser and, for the first time, the position will also hold a seat in the Cabinet.

At a time that is often referred to as “The Age of Technology,” the U.S. has no coherent strategy for maintaining its high standing as a world leader in science, technology and innovation, and has watched as China has overtaken the country on many indicators of prowess in R&D and innovation.

The White House Office of Science and Technology Policy (OSTP) is exploring a national strategy to promote the U.S. bioeconomy. In response to a request for information, SSTI submitted a letter encouraging OSTP to leverage existing regional assets as part of its approach. To see more innovations converted into new products, services and businesses, the letter encourages a new program to fund commercialization assistance and to strengthen SBIR.

President Donald Trump this week issued an executive order reinstituting the President’s Council of Advisors on Science and Technology (PCAST) to advise the president on matters involving science, technology, education, and innovation policy and named the first seven people to the council.

Last week, U.S. Air Force secretary Heather Wilson released a new Science and Technology Strategy outlining three broad areas for realignment within the branch. The secretary’s emphasis on transformational partnerships should be particularly noteworthy for non-defense organization working with new technologies or STEM workforce.

In January, the U.S. Senate confirmed Dr. Kelvin Droegemeier as director of the White House Science and Technology Policy (OSTP), and since the end of the partial federal government shutdown, the director and office have produced informative reports and speeches. Two common threads through these sources are emphases on continued American leadership in key tech sectors — and that this leadership will increasingly occur in conjunction with, or under the direction of, private industry.